| Literature DB >> 12031318 |
R P Alexander1, G J Warrellow, M A W Eaton, E C Boyd, J C Head, J R Porter, J A Brown, J T Reuberson, B Hutchinson, P Turner, B Boyce, D Barnes, B Mason, A Cannell, R J Taylor, A Zomaya, A Millican, J Leonard, R Morphy, M Wales, M Perry, R A Allen, N Gozzard, B Hughes, G Higgs.
Abstract
The discovery, synthesis and biological activity of a series of triarylethane phosphodiesterase 4 inhibitors is described. Structure-activity relationship studies are presented for CDP840 (29), a potent, chiral, selective inhibitor of PDE 4 (IC(50) 4nM). CDP840 is non-emetic in the ferret at 30mgkg(-1) (po), active in models of inflammation and reverses ozone-induced bronchial hyperreactivity in the guinea pig.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12031318 DOI： 10.1016/s0960-894x(02)00202-0
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823